Association of adiponectin and metabolic syndrome in adolescents: the caspian- III study

[1]  Vandana S. Raman,et al.  Metabolic syndrome in children and adolescents. , 2017, Translational pediatrics.

[2]  M. Abu-Farha,et al.  Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs , 2014, Cardiovascular Diabetology.

[3]  L. Kolonel,et al.  Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort , 2014, International Journal of Obesity.

[4]  R. Bayoumi,et al.  Association of adiponectin promoter variants with traits and clusters of metabolic syndrome in Arabs: family-based study. , 2013, Gene.

[5]  J. Vieira,et al.  Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects , 2013, Cardiovascular Diabetology.

[6]  K. Blaslov,et al.  Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients , 2013, International journal of endocrinology.

[7]  S. Yusuf,et al.  Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population , 2013, PloS one.

[8]  G. Vilahur,et al.  Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome , 2013, Mediators of inflammation.

[9]  S. Grundy,et al.  Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio , 2013, Journal of obesity.

[10]  Y. Matsuzawa,et al.  Association of adiponectin with blood pressure in healthy people , 2013, Clinical endocrinology.

[11]  R. Wildman,et al.  Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). , 2012, Metabolism: clinical and experimental.

[12]  R. Kelishadi,et al.  Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students’ High Risk Behaviors , 2012, International journal of preventive medicine.

[13]  G. Reaven,et al.  The metabolic syndrome: time to get off the merry‐go‐round? , 2011, Journal of internal medicine.

[14]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[15]  J. Flynn,et al.  Relationship Between Adiponectin and Ambulatory Blood Pressure in Obese Adolescents , 2009, Pediatric Research.

[16]  F. Greenway,et al.  Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. , 2009, Archives of pediatrics & adolescent medicine.

[17]  M. Forouzanfar,et al.  First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East , 2009, Diabetes Care.

[18]  P. Scherer,et al.  Adiponectin, Cardiovascular Function, and Hypertension , 2008, Hypertension.

[19]  W. Garvey,et al.  Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease , 2007, Current opinion in lipidology.

[20]  L. Gilardini,et al.  Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. , 2006, Atherosclerosis.

[21]  Y. Kesäniemi,et al.  Low plasma adiponectin concentration is an indicator of the metabolic syndrome. , 2006, European journal of endocrinology.

[22]  G. Sweeney,et al.  Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. , 2006, Biochemical Society transactions.

[23]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[24]  N. Chu,et al.  Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children. , 2005, Obesity research.

[25]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[26]  R. Martos,et al.  Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. , 2005, Diabetes & metabolism.

[27]  S. Ishibashi,et al.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. , 2003, Metabolism: clinical and experimental.

[28]  A. Shirahata,et al.  Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. , 2003, Obesity research.

[29]  M. Cnop,et al.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.

[30]  M. Stumvoll,et al.  Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. , 2003, Diabetes.

[31]  G. Yoshino,et al.  Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. , 2002, Diabetes care.

[32]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[33]  E. Rimm,et al.  Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan—The Taipei Children Heart Study , 2000, International Journal of Obesity.

[34]  T. Funahashi,et al.  Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive Substances , 1999, Annals of the New York Academy of Sciences.

[35]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.